CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Metagenomi Therapeutics, Inc.
Sign in to watch- Ticker
- MGX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 813909017
- Phone
- (510) 871-4880
- Business address
- 5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
- Former names
- Metagenomi, Inc., Metagenomi Technologies, LLC
- Open-market buys, last 90 days
- $23,401
- in 1 filing
- Open-market sales, last 90 days
- $5,107
- in 3 filings
Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Irish Jian Chief Executive Officer | Sale | −1,607 | $1.60 | $3K | 333,770 |
| 2025-12-05 | Irish Jian Chief Executive Officer | Gift | −228,462 | 335,377 | ||
| 2025-12-05 | Thomas Brian C. Director | Sale | −3,830 | $1.77 | $7K | 2,510,960 |
| 2025-12-05 | Wein Matthew See Remarks | Sale | −199 | $1.77 | $353 | 115,031 |
| 2025-12-05 | Wapnick Pamela Chief Financial Officer | Sale | −1,576 | $1.77 | $3K | 188,956 |
| 2025-12-05 | Irish Jian Chief Executive Officer | Sale | −1,602 | $1.77 | $3K | 563,839 |
| 2025-12-01 | Wapnick Pamela Chief Financial Officer | Grant or award | +120,000 | $1.60 | $192K | 190,532 |
| 2025-12-01 | Irish Jian Chief Executive Officer | Grant or award | +37,500 | $1.60 | $60K | 354,441 |
| 2025-12-01 | Irish Jian Chief Executive Officer | Grant or award | +211,000 | $1.60 | $338K | 565,441 |
| 2025-12-01 | Irish Jian Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-12-01 | Wein Matthew See Remarks | Grant or award | +96,000 | $1.60 | $154K | 115,230 |
| 2025-09-05 | Thomas Brian C. Director | Sale | −2,701 | $1.81 | $5K | 2,514,790 |
| 2025-09-05 | Wapnick Pamela Chief Financial Officer | Sale | −1,576 | $1.81 | $3K | 70,532 |
| 2025-09-05 | Irish Jian Chief Executive Officer | Sale | −1,602 | $1.81 | $3K | 316,941 |
| 2025-09-05 | Wein Matthew See Remarks | Sale | −199 | $1.81 | $360 | 19,230 |
| 2025-09-02 | Reid Laurence Director | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2025-06-10 | Eckhardt Juergen Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2025-06-10 | Dere Willard H Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2025-06-10 | BJERKHOLT ERIC Director | Grant or award · Stock Option (Right to Buy) | +8,572 | 8,572 | ||
| 2025-06-06 | Wein Matthew See Remarks | Sale | −199 | $1.75 | $348 | 16,693 |
Page 2 of 6 · 101 trades